SCHEMBL9844800

SCHEMBL9844800

N#[N+]c1cc(Cl)ccc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.36
CYP3A4 P08684 4/20 0.36
TP53 P04637 2/20 0.35
ALDH1A1 P00352 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
ALOX15 P16050 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP2A6 P11509 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 2/20 0.31
AHR P35869 1/20 0.31
S100A4 P26447 1/20 0.30
KMT2A Q03164 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4067475 0.94 CYP3A4 (0.32) TSHRCYP3A4TP53
SCHEMBL27631424 0.92 CYP3A4 (0.31) TSHRCYP3A4TP53
SCHEMBL14701096 0.84 CCR2 (0.34) TSHRCYP3A4TP53ALDH1A1TDP1
SCHEMBL9844828 0.79 CCR2 (0.32) TP53SMN1; SMN2KMT2AHTR2AHTR2C
SCHEMBL6422615 0.78 TP53 (0.48) TSHRCYP3A4TP53ALDH1A1TDP1
SCHEMBL5182959 0.78 CA3 (0.42) ALDH1A1TDP1CYP2A6CYP1A2
Hydrochloric Acid SCHEMBL9488013 0.76 TP53 (0.46) TSHRCYP3A4TP53ALDH1A1TDP1
SCHEMBL12190382 0.76 TP53 (0.35) TSHRCYP3A4TP53ALDH1A1TDP1
SCHEMBL30739512 0.76 TP53 (0.41) TSHRCYP3A4TP53ALDH1A1TDP1
SCHEMBL9745484 0.76 TP53 (0.41) TSHRCYP3A4TP53ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348440-B2 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator MERCK & CO., INC. (US) 2008-03-25 US disclosed
WO-1991013847-A1 PROCESS FOR PREPARING CHLORO-DIFLUOROBENZENE ISC CHEMICALS LIMITED (GB) 1991-09-19 WO disclosed
EP-0447259-A1 Process for preparing chloro-difluorobenzene ISC CHEMICALS LIMITED (GB) 1991-09-18 EP disclosed